Terbinafine Hydrochloride Price Trend

Terbinafine Hydrochloride Prices December 2023

In the fourth quarter of 2023, the manufacturing sector of India seemed to slow down as the new orders, output, exports, and invoices all showed a downtrend. Increasing the terbinafine hydrochloride stock and the drop in demand due to a lesser number of fungal cases in winter led to a price decrease. Despite the quarterly downturn, market analysts remain optimistic about future price stability and potential increases, attributing this bullish outlook to expectations of a rebound in demand. Q4 2023 price of terbinafine hydrochloride reached 62466 USD/MT.

Terbinafine Hydrochloride Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Terbinafine Hydrochloride Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of terbinafine hydrochloride pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of terbinafine hydrochloride at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of terbinafine hydrochloride price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing terbinafine hydrochloride price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Terbinafine Hydrochloride Market Analysis

The global terbinafine hydrochloride market size reached US$ 1.2 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 3 Billion, at a projected CAGR of 10.50% during 2023-2032.

• Continual advancements in pharmaceutical formulations and manufacturing processes contribute to product innovation and market expansion.
• The strategic partnerships and collaborations among pharmaceutical companies facilitate market growth and penetration into emerging economies.
• An enhanced focus on healthcare and dermatological wellness fuels the demand for Terbinafine Hydrochloride-based treatments.
• Regulatory approvals and compliance standards play a crucial role in market access and product adoption, influencing market dynamics and competitiveness.
• The growing adoption of telemedicine and e-pharmacies facilitates easier access to Terbinafine Hydrochloride products, particularly in remote or underserved areas.
• The lifestyle changes, including increased participation in sports and outdoor activities, elevate the risk of fungal infections, further stimulating market demand for antifungal treatments like Terbinafine Hydrochloride.
• The evolving consumer preferences towards self-care and over-the-counter (OTC) medications drive sales of Terbinafine Hydrochloride products in retail pharmacies and online platforms.
• The emergence of novel drug delivery systems and formulations enhances patient compliance and convenience, fostering market growth by expanding the range of available treatment options.
• The rise in healthcare expenditure and access to healthcare services in developing regions fosters market growth by expanding the patient pool seeking treatment for fungal infections.
• Rapid globalization of travel and trade facilitates the spread of fungal pathogens across borders, resulting in a more significant global market for Terbinafine Hydrochloride products.
• Increasing number of public health awareness campaigns and educational initiatives regarding fungal infections raise awareness about the availability and efficacy of Terbinafine Hydrochloride treatments, stimulating market demand.
• Increasing disposable incomes in developing countries enable individuals to afford healthcare expenditures, including medications for treating fungal infections.

Terbinafine Hydrochloride News

The report covers the latest developments, updates, and trends impacting the global terbinafine hydrochloride market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in terbinafine hydrochloride production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the terbinafine hydrochloride price trend.

Latest developments in the terbinafine hydrochloride industry:

• In 2024, Novartis revealed ALITHIOS study data demonstrating Kesimpta's sustained efficacy over six years for treatment-naïve individuals with relapsing multiple sclerosis: 44% fewer relapses, 96.4% and 82.7% MRI lesion reductions, and 24.5% and 21.6% fewer 3- and 6-month disability worsening events compared to teriflunomide switchers. Similar efficacy and safety were observed across the ALITHIOS population.
• In 2023, Taro Pharmaceutical Industries Ltd. (PINK SHEETS: (TAROF) Celebrates FDA's Final Approval of Its Abbreviated New Drug Application (ANDA) Submission for Terbinafine Hydrochloride Cream, 1%. This implies conditional approval, which is a step towards the drug pipeline expansion of Taro Biopharm.
• In 2021, Breckenridge Pharmaceutical, Inc. announced a multi-product agreement with Aggrega Pharma, LLC., covering eight products in various dosage forms. The agreement includes one approved ANDA, four submitted to the FDA, and three in advanced development stages.

Product Description

Terbinafine Hydrochloride is an active pharmaceutical ingredient that is majorly employed for the treatment of superficial fungal infections of the skin and nails such as athlete's foot, jock itch, and ringworm. It is a representative of the class of antifungal drugs known as allylamines, which work on ergosterol synthesis inhibition reducing the membrane function, andergogenicity, and growth and reproduction of fungi. The compound is commonly prepared in the laboratory by the multi-step oxidation of the starting compounds to produce the active ingredient.

Terbinafine hydrochloride occupies an important position in dermatology and podiatry being a very effective drug for the cure of skin and nail fungal infections and, therefore, a pain relief as well as a relief from itching, redness, scaling, and discomfort. The advantages, such as high therapeutic efficacy, easy application, and fewer potential adverse reactions than others are the main features. Terbinafine hydrochloride is present widely in both over-the-counter and prescription formulations, which makes it available to patients with curative effects and simple treatment modalities for fungal infections targeting the skin and nails.

Regional Coverage

The report provides a detailed analysis of the terbinafine hydrochloride market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the terbinafine hydrochloride price trend.

Global Terbinafine Hydrochloride Price

The report offers a holistic view of the global terbinafine hydrochloride pricing trends in the form of terbinafine hydrochloride price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of terbinafine hydrochloride but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed terbinafine hydrochloride demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Terbinafine Hydrochloride Price

The fourth quarter of 2023 in Europe was characterized by price changes impacted by several factors, of the terbinafine hydrochloride market. Foreign exchange fluctuations, monetary tightening, and deteriorating consumer morale were among the factors that affected the situation. Consumers' spending and consumption shrank significantly, and a notable deficit in demand for terbinafine hydrochloride ensued since high interest rates hampered individuals' economic capacity. Moreover, the strengthening of the euro against the US dollar paved the way for low-cost imports, offering a large amount of the drug in the German market.

This analysis can be extended to include detailed terbinafine hydrochloride price information for a comprehensive list of countries.

North America Terbinafine Hydrochloride Price

The fourth quarter of 2023 in North America was marked by the occurrence of several key factors which affected the pricing dynamics of Terbinafine Hydrochloride. Firstly, the prices went slightly down in the context of shrinking demand from the pharmaceutical and healthcare sector bringing up an oversupply situation. However the Federal Reserve Bank as a result supported by its interest rates since the sustained levels plays a significant role in reducing consumer purchasing power and adding to the downward trend in the price of goods.

Specific terbinafine hydrochloride historical data within the United States and Canada can also be provided.

Middle East and Africa Terbinafine Hydrochloride Price

The report explores the terbinafine hydrochloride pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on terbinafine hydrochloride prices for countries can also be provided.

Asia Pacific Terbinafine Hydrochloride Price

Terbinafine hydrochloride price fluctuation in the APAC region during the fourth quarter of 2023 was affected by several factors. The major factor, specifically the fallout in demand from the pharmaceutical and healthcare sectors, was the price decrease. In addition, a greater stockpile of terbinafine hydrochloride, brought the prices point further down. Additionally, the contraction in the advanced economies and slowing down global trade that followed hindered exports and led to dull investor sentiment. In particular, the Indian manufacturing sector as of the fourth quarter experienced a slowdown, which was indicated by falling order intake, production levels, export development, and purchasing activity. These decreased demands accompanied by the excess supply at home resulted in low terbinafine hydrochloride prices in India.

This terbinafine hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Terbinafine Hydrochloride Price

The analysis of terbinafine hydrochloride prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of terbinafine hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting terbinafine hydrochloride price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The terbinafine hydrochloride price charts ensure our clients remain at the forefront of the industry.